THE TURNER’S FUNDRAISER FOR CURE ALZHEIMER'S FUND

As many of you know, John is one of the 6 million people in the United States living with Alzheimers. When he received the diagnosis 6 ½ years ago it shocked and devastated us. He was 52 with no family history of the disease and otherwise very healthy. Since John’s own diagnosis we have learned that this disease can strike anyone at any time.

With John, Alzheimers started as an occasional and unexplained loss for words or lapse in understanding. It has progressed over the years to affect many parts of his life; deteriorated speech and ability to express himself, loss of driving ability, and overall decrease in independence. While Alzheimers has taken a lot, John is a relentless fighter. Since the time of his diagnosis, he has fought like hell to slow the progression of the disease following every recommendation from his doctors. It is not an easy road and he misses his old self. But we are committed to not giving up hope.

One of the ways we keep hope alive is by reading about the research that is going on in the field of Alzheimer’s. Pretty early on, we found Cure Alzheimer’s Fund. The research they were funding inspired us, and it gave us hope knowing this organization's mission is to find a cure for Alzheimer’s. Over the years, we have gotten to know some of the doctors that have received grants from Cure Alzheimer’s, and we can tell you they are not only brilliant but have committed their lives to helping patients who have been given this diagnosis. Below is an informative fact sheet about Cure Alzheimer’s Fund. Please join us in supporting this incredible organization. We appreciate any donations and 100% of the proceeds will go to Cure Alzheimer’s Fund.

Cure Alzheimer’s Fund 101

To help you answer some basic questions at your event, we have compiled everything you need to know about Cure Alzheimer’s Fund and Alzheimer’s disease below.

• 6.5 million Americans are living with Alzheimer’s in 2022. By 2050, this number is projected to rise to over 14 million.

• Two-thirds of Alzheimer’s patients are women

• In 2022, Alzheimer’s and dementia will cost the US $355 billion. By 2050, the number could rise to $1.1 trillion.

• Over 11 million Americans provide an estimated 15 billion hours in unpaid care for people with Alzheimer’s or other forms of dementia, valued at nearly $257 billion

• 1 in 3 seniors dies with Alzheimer’s or another form of dementia.

• CureAlz is dedicated to funding research with the highest probability of stopping, slowing and preventing Alzheimer’s disease. Our board covers all operating costs so that 100% of every donation can go directly to Alzheimer’s research.

• Since inception, CureAlz has directed over $150 million to Alzheimer’s research. This money has funded more than 500 projects at 78 world-class institutions around the globe.

• CureAlz requires collaboration among our funded researchers. Our Research Leadership Group meets annually as well as holding quarterly conference calls to discuss their work, the latest Alzheimer’s developments, and guide our research funding.

• CureAlz provides seed funding to get high-risk, high-reward projects off the ground that are deemed too risky for larger organizations like the National Institutes of Health.

• CureAlz primary focus is funding foundational research looking at the pathology of the disease. Most drug trials fail because we don’t fully understand how Alzheimer’s begins and spreads. CureAlz is striving to change that.

• CureAlz has received a perfect 4-star rating from the charity watchdog site Charity Navigator for the past 10 consecutive years.

• CureAlz is listed as a Platinum charity on Guidestar